BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 27130315)

  • 21. Changes in kynurenine metabolites in the gray and white matter of the dorsolateral prefrontal cortex of individuals affected by schizophrenia.
    Antenucci N; D'Errico G; Fazio F; Nicoletti F; Bruno V; Battaglia G
    Schizophrenia (Heidelb); 2024 Feb; 10(1):27. PubMed ID: 38413629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Metabolic Profiles of the Tryptophan-Kynurenine Pathway in the high risk subjects of major depressive disorder.
    Sakurai M; Yamamoto Y; Kanayama N; Hasegawa M; Mouri A; Takemura M; Matsunami H; Miyauchi T; Tokura T; Kimura H; Ito M; Umemura E; Boku AS; Nagashima W; Tonoike T; Kurita K; Ozaki N; Nabeshima T; Saito K
    Sci Rep; 2020 Feb; 10(1):1961. PubMed ID: 32029791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultra-performance liquid chromatography-tandem mass spectrometry quantitative profiling of tryptophan metabolites in human plasma and its application to clinical study.
    Chen Y; Chen H; Shi G; Yang M; Zheng F; Zheng Z; Zhang S; Zhong S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Oct; 1128():121745. PubMed ID: 31586884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single-run liquid chromatography mass spectrometry method to quantify neuroactive kynurenine pathway metabolites in rat plasma.
    Orsatti L; Speziale R; Orsale MV; Caretti F; Veneziano M; Zini M; Monteagudo E; Lyons K; Beconi M; Chan K; Herbst T; Toledo-Sherman L; Munoz-Sanjuan I; Bonelli F; Dominguez C
    J Pharm Biomed Anal; 2015 Mar; 107():426-31. PubMed ID: 25668794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes.
    Oxenkrug GF
    Mol Neurobiol; 2015 Oct; 52(2):805-10. PubMed ID: 26055228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Kynurenic Acid on Pupae Viability of Drosophila melanogaster cinnabar and cardinal Eye Color Mutants with Altered Tryptophan-Kynurenine Metabolism.
    Navrotskaya V; Wnorowski A; Turski W; Oxenkrug G
    Neurotox Res; 2018 Aug; 34(2):324-331. PubMed ID: 29619629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quantitative analysis of tryptophan and its metabolites in urine by ultra performance liquid chromatography-tandem mass spectrometry].
    Li H; Cui L; Zhang G; Zhang M; Jiao L; Wu W
    Se Pu; 2021 May; 39(5):518-525. PubMed ID: 34227336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
    Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Hajibeygi R; Shool S; Sodeifian F; Klegeris A; McElhinney A; Tavirani MR; Sayehmiri F
    Front Immunol; 2022; 13():997240. PubMed ID: 36263032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism.
    Fukui S; Schwarcz R; Rapoport SI; Takada Y; Smith QR
    J Neurochem; 1991 Jun; 56(6):2007-17. PubMed ID: 1827495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.
    Savitz J; Dantzer R; Wurfel BE; Victor TA; Ford BN; Bodurka J; Bellgowan PS; Teague TK; Drevets WC
    Psychoneuroendocrinology; 2015 Feb; 52():200-11. PubMed ID: 25486577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between intake of fish and n-3 long-chain polyunsaturated fatty acids and plasma metabolites related to the kynurenine pathway in patients with coronary artery disease.
    Karlsson T; Strand E; Dierkes J; Drevon CA; Øyen J; Midttun Ø; Ueland PM; Gudbrandsen OA; Pedersen ER; Nygård O
    Eur J Nutr; 2017 Feb; 56(1):261-272. PubMed ID: 26482150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kynurenine pathway changes in late-life depression.
    Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
    J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kynurenine Pathway Metabolites in Alzheimer's Disease.
    Giil LM; Midttun Ø; Refsum H; Ulvik A; Advani R; Smith AD; Ueland PM
    J Alzheimers Dis; 2017; 60(2):495-504. PubMed ID: 28869479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous measurement of kynurenine metabolites and explorative metabolomics using liquid chromatography-mass spectrometry: A novel accurate method applied to serum and plasma samples from a large healthy cohort.
    Eggertsen PP; Hansen J; Andersen ML; Nielsen JF; Olsen RKJ; Palmfeldt J
    J Pharm Biomed Anal; 2023 Apr; 227():115304. PubMed ID: 36827735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kynurenine and its metabolites--kynurenic acid and anthranilic acid are associated with soluble endothelial adhesion molecules and oxidative status in patients with chronic kidney disease.
    Pawlak K; Kowalewska A; Mysliwiec M; Pawlak D
    Am J Med Sci; 2009 Oct; 338(4):293-300. PubMed ID: 19745702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures.
    Muñóz-Hoyos A; Molina-Carballo A; Rodríguez-Cabezas T; Uberos-Fernández J; Ruiz-Cosano C; Acuña-Castroviejo D
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):667-77. PubMed ID: 9497873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kynurenine pathway in Coronavirus disease (COVID-19): Potential role in prognosis.
    Cihan M; Doğan Ö; Ceran Serdar C; Altunçekiç Yıldırım A; Kurt C; Serdar MA
    J Clin Lab Anal; 2022 Mar; 36(3):e24257. PubMed ID: 35092710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.